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The type VI secretion system (T6SS) delivers toxic effectors
betweenGram-negative bacteria.Most antibacterial T6SS effec-
tors are peptidoglycanases, nucleases, or lipases. In the current
work, Tang et al. structurally and functionally characterize a
novel family ofNAD(P)-hydrolyzing effectors (NADases), thus
expanding the documented types of T6SS substrates. Bioinfor-
matic identification of NADase family members putatively
secreted by the bacteriolytic type VII secretion system (T7SS) of
Gram-positive bacteria further points to NADases as a diverse
and important class of effectors.
Bacterial species most often exist as part of a highly orga-
nized, dynamic community (1). Howbacterial species can coex-
ist with, or dominate, other organisms is a valuable area of
research, as it not only provides fundamental knowledge of how
diverse bacterial communities are established and maintained
but also has clinical relevance for the treatment of pathogens,
which need to compete with the host microbiota or other
potential host pathogens to establish a niche. Bacteria employ a
variety of secretory mechanisms to mediate interbacterial
interactions. Contact-dependent antagonistic interactions
among Gram-negative bacteria are mediated by the T6SS2 (2),
whereas the T7SS is thought to be involved in those occurring
among Gram-positive Firmicutes (3, 4). In either case, the
breadth of molecules mediating interbacterial killing remains
only partially characterized.
The T6SS structurally resembles an inverted bacteriophage
tail anchored to the bacterial cell wall via a membrane-associ-
ated complex. The “tail” is composed of a sheath complex that
encompasses a spiked tube. When the sheath contracts, it pro-
pels the spiked tube across both bacterial membranes and into
adjacent cells (5). Secretion of effectors by this system requires
associationwith one of the structural components of the spiked
tube, hemolysin-coregulated protein (Hcp), valine–glycine
repeat protein G (VgrG), or proline–alanine–alanine–arginine
(PAAR) repeat proteins. Associations can be either physical, via
protein–protein interactions, or genetic, as C-terminal exten-
sions of structural T6SS components (5). Thus, proteins that
possess a PAAR domain are putative T6SS effectors. Bacteria
harboring T6SS effectors are protected from self-intoxica-
tion by immunity proteins, which specifically inactivate their
cognate toxin. Proteomic, genetic, and bioinformatic studies
have revealed that most antibacterial T6SS effectors are
peptidoglycanases, lipases, or nucleases (6); however, a pre-
vious report identified the T6SS effector Tse6 of Pseudomo-
nas aeruginosa as an NADase (7). Until now, it had been
largely unknown whether NADase effectors are unique to P.
aeruginosa or whether they represent a novel class of T6SS
effectors.
In the current work, Tang et al. (8) searched for proteins
containing PAARdomains in the genomeof the plant commen-
sal Pseudomonas protegens and identified two hypothetical
T6SS effectors, RhsA (PFL_6096) and Tne2 (PFL_6209). RhsA
shared homology with proteins of the rearrangement hotspot
family of T6SS effectors, which commonly function as
nucleases. In contrast, Tne2 lacked homology to any protein of
known function. Bacterial competition assays showed that both
RhsA and Tne2 provide P. protegens a T6SS-dependent fitness
advantage over P. putida, leading the authors to investigate the
specific function of Tne2. To this end, the 1.7-Å X-ray crystal
structure of the novel T6SS effector in complex with its immu-
nity protein Tni2 (PFL_6210) was determined. The structure of
Tne2 showed substantial similarity to that of the previously
identified T6SS NADase Tse6 (7), suggesting that Tne2 could
function as an NADase. Indeed, the authors showed that Tne2
degrades NAD(P) in vitro by cleaving the nicotinamide group.
Furthermore, Tne2 reduces cellular NAD levels when
expressed heterologously in Escherichia coli, and this activ-
ity is abrogated by mutation of residues modeled as having
direct contact with the NAD substrate. Altogether, the data
indicate that the T6SS effector Tne2 of P. protegens is a bona
fide NADase.
Despite the structural similarities betweenTse6 andTne2 (7,
8), these two effectors also present considerable differences,
specifically in their respective activating loops and NAD-
binding pockets. Moreover, the cognate immunity protein for
each effector, Tsi6 and Tni2, respectively, present prominent
differences in their overall folds. Accordingly, Tsi6 neither
interacts with Tne2 nor prevents Tne2-based toxicity. In light
of these results, the authors proposed that Tse6 and Tne2 rep-
resent two distinct families of T6SS NADases. Because Tse6
was identified first, it was designated as amember of the typeVI
secretionNADase effector family 1 (Tne1), whereas Tne2 is the
founding member of the Tne2 family. Bioinformatic analysis
revealed more than 100 orthologous proteins and putative
T6SS effectors for each family. Remarkably, nearly 50 addi-
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tional Tne2 orthologs contain predicted LXG or WXG-100
domains at their N terminus. Because LXG andWXG-100 pro-
teins are substrates of the T7SS (4), these results suggest that
NADases may represent a prevalent class of effectors secreted
by both Gram-positive and Gram-negative bacteria to mediate
interbacterial interactions (Fig. 1).
The current study thus characterizes a novel class of T6SS
effectors that has, until now, been largely underappreciated.
Structural comparisons between Tne2 and the only other
NADase T6SS effector characterized to date, Tse6 (7),
enabled the authors to define the two effectors as foundingmem-
bers of two novel families of NADases, Tne2 and Tne1, respec-
tively. Furthermore, the finding that a subset of Tne2 orthologs
possesses domains associated with T7SS effectors indicates that
the T6SS and T7SSmay translocate similar toxins to vastly differ-
entbacterial cell types.However, itmust benoted that theputative
T7SS NADases have yet to be validated.
The authors also found that the previously identified T6SS
effectors of P. protegens, namely Tge2, Tae3, and Tse4, appear
not to be involved in bacterial antagonism under the experi-
mental condition tested. The finding of T6SS effectors with no
observable antibacterial activity has also been documented for
Acinetobacter baumannii (9, 10). It is possible that the role of
these effectors is dependent on environmental conditions, as
was determined for Tge2 (8), or that they have eukaryotic targets.
Furthermore, these effectors may play other roles (e.g. nutrient
acquisition) or may represent novel classes of uncharacterized
effectors. Altogether, the findings of this study provide a wealth of
information for future investigation and greatly improve our
understanding of the plethora ofmolecules thatmediate interbac-
terial interactions. Furthermore, the finding of this novel effector
class broadens the possible targets for innovative antimicrobials.
Molecules targeting bacterial dinucleotidemetabolism could con-
stitute the basis for novel antibacterial strategies.
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Figure1.NADaseeffector families Tne1andTne2mediate interbacterial
antagonism. The T6SS of Gram-negative bacteria (solid black arrows)
secretes toxic NADase effectors fromboth Tne families into adjacent bacteria
(7, 8). Similarly, Gram-positive bacteria encode Tne2 orthologs possessing
domains that suggest they are secreted by the T7SS (dashed black line); how-
ever, this remains to be experimentally shown (see text for details).
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